EUVIMEDEUVIMED entdecken
Open Access · CC BY 2.0

Novel Biomarkers for Tuberculosis: Towards Affordable and Reliable Diagnostic Solutions

Meti Kusmiati, Shabarni Gaffar, Sri Agung Fitri Kusuma

Indonesian Journal of Pharmacy · 02.03.2026 · 1-17

DOI: 10.22146/ijp.18011 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Indonesian Journal of Pharmacy, online erschienen am 02.03.2026. Verfasst von Meti Kusmiati und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 2.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tuberculosis remains a significant global health challenge—a situation further exacerbated by the COVID-19 pandemic, which has disrupted diagnosis and treatment efforts. Despite being preventable and curable, TB continues to be a major threat, ranking among the leading causes of infectious disease mortality. The unreliability and unaffordability of current diagnostic procedures underscore the need for new biomarkers and point-of-care testing solutions. Recent research has identified several potential biomarkers for diagnosing TB and differentiating between active and latent infections. This study was aimed to assess and identify a spectrum of biomarkers tuberculosis, including those for vaccine-induced protection, TB disease, TB risk, TB infection, and response to TB treatment. Article are identified from PubMed database with keyword tuberculosis, Biomarker, Diagnosis, Kit based on inclusion and exclusion criteria. Biomarkers of vaccine induced protection is Rv1566-444. Biomarker of TB infection such as IP-10, IFN-γ, Ferritin and 25(OH)D; IL-1ra, IL-1β and GM-CSF; Fibronectin; HMGB1; Tpx-IgA, NCAM-1, vitronectin, CFH, Ferritin and α-2-macroglobulin; M. tuberculosis β-lactamase. Biomarkers of TB risk namely IFN-γ. Biomarker of TB infection consist of CCl6, IFN-γ, TIMP-1, IP-10/CCL19 and Ag85B. Biomarker of response to TB treatment such as IL-1β; IP-10 and suPAR. The most promising host biomarkers are IP-10 and IFN-γ, while Ag85B stands out as the most promising pathogen biomarker.

Zitieren

APA

Kusmiati, M., Gaffar, S., & Kusuma, S. A. F. (2026). Novel Biomarkers for Tuberculosis: Towards Affordable and Reliable Diagnostic Solutions. Indonesian Journal of Pharmacy, 1-17. https://doi.org/10.22146/ijp.18011

Vancouver

Kusmiati M, Gaffar S, Kusuma SAF. Novel Biomarkers for Tuberculosis: Towards Affordable and Reliable Diagnostic Solutions. Indonesian Journal of Pharmacy. 2026:1-17. doi:10.22146/ijp.18011

BibTeX
@article{Kusmiati2026,
  author = {Kusmiati, Meti and Gaffar, Shabarni and Kusuma, Sri Agung Fitri},
  title = {Novel Biomarkers for Tuberculosis: Towards Affordable and Reliable Diagnostic Solutions},
  journal = {Indonesian Journal of Pharmacy},
  year = {2026},
  pages = {1--17},
  doi = {10.22146/ijp.18011}
}
Kostenlos starten →